GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hadasit Bio Holdings Ltd (OTCPK:HSITF) » Definitions » Growth Rank

Hadasit Bio Holdings (Hadasit Bio Holdings) Growth Rank : 0 (As of May. 18, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hadasit Bio Holdings Growth Rank?

Hadasit Bio Holdings has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Hadasit Bio Holdings Growth Rank Related Terms

Thank you for viewing the detailed overview of Hadasit Bio Holdings's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Hadasit Bio Holdings (Hadasit Bio Holdings) Business Description

Traded in Other Exchanges
Address
5th Floor, Jerusaelm Bio-Park, Hadassah Ein-Kerem Campus, Jerusalem, ISR, 91120
Hadasit Bio Holdings Ltd serves as a precedent in the field of biotech financing. It is engaged in the advancement and enhancement of its portfolio companies. Its portfolio companies are involved in the field of medical and biotechnological research and production and distribution of the results of the research and development done in these areas.